Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Common Stock | +Grant/Award | $7,718 | +55 | +17.68% | $140.33 | 366 | Dec 30, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Deferred Stock Units | +Grant/Award | $0 | +8 | +0.82% | $0.00 | 948 | Nov 10, 2022 | Common Stock | 8 | Direct | F2, F3, F4 | |
transaction | CLX | Deferred Stock Units | +Grant/Award | $0 | +1,073 | +113.22% | $0.00 | 2,021 | Dec 30, 2022 | Common Stock | 1,073 | Direct | F2, F4, F5 |
Id | Content |
---|---|
F1 | Receipt of Common Stock in lieu of portion of quarterly director's fee. |
F2 | 1-for-1 |
F3 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
F4 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
F5 | Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. |